관동맥질환 치료의 최신 지견 (Updates in the Management of Coronary Artery Disease) |
Author |
양동헌·채성철, |
Dong Heon Yang, M.D., Shung Chull Chae, M.D. |
Affiliation |
경북대학교 의과대학 순환기내과 Division of Cardiology, Department of Internal Medicine, Kyungpook National University Medical School, Daegu, Korea |
Abstract |
Coronary artery disease (CAD) has been increasing during the last decade and is the one of major causes of
death. The management of patients with coronary artery disease has evolved considerably. There are two main
strategies in the management of CAD, complementary, not competitive, each other; the pharmacologic therapy to
prevent and treat CAD and the percutaneous coronary intervention (PCI) to restore coronary flow. Antiplatelet
drugs and cholesterol lowering drugs have central roles in pharmacotherapy. Drug eluting stent (DES) bring about
revolutional changes in PCI. In the management of patients with ST segment elevation acute myocardial infarction
(AMI), there has been a debate on the better strategy for the restoration of coronary flow. Thrombolytic therapy
is widely available and easy to administer, whereas primary PCI is less available and more complex, but more
complete. Recently published evidences in the pharmacologic therapy including antiplatelet and statin, and PCI
including DES and reperfusion therapy in patients with ST segment elevation AMI were reviewed.(Korean J Nucl
Med 39(2):87-93, 2005) |
Keyword |
Coronary artery disease, Antiplatelet, Statin, Drug eluting stent, Acute myocardial infarction |
Full text Article |
39020087.pdf
|
|
|